Alok Industries Limited (NSE:ALOKINDS)

India flag India · Delayed Price · Currency is INR
18.70
-0.30 (-1.58%)
Aug 1, 2025, 3:30 PM IST

Inozyme Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Aug '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
92,85074,727128,35157,597125,869100,050
Upgrade
Market Cap Growth
-26.86%-41.78%122.84%-54.24%25.81%1050.29%
Upgrade
Enterprise Value
351,762332,858366,734299,892366,395334,980
Upgrade
Last Close Price
18.7015.0525.8511.6025.3520.15
Upgrade
PS Ratio
2.552.022.330.821.722.60
Upgrade
PB Ratio
-0.45-0.36-0.65-0.30-0.70-0.57
Upgrade
P/FCF Ratio
-208.44-7.49106.8084.75
Upgrade
P/OCF Ratio
-64.86-7.0855.9828.98
Upgrade
EV/Sales Ratio
9.688.986.664.295.018.71
Upgrade
EV/EBITDA Ratio
--719.23-64.71115.00
Upgrade
EV/EBIT Ratio
----163.35-
Upgrade
EV/FCF Ratio
-928.47-38.99310.90283.76
Upgrade
Debt / Equity Ratio
-1.26-1.26-1.31-1.28-1.36-1.37
Upgrade
Debt / EBITDA Ratio
--469.24-42.9782.91
Upgrade
Debt / FCF Ratio
-724.21-31.42206.55204.77
Upgrade
Asset Turnover
-0.530.740.890.900.29
Upgrade
Inventory Turnover
-2.983.824.414.383.19
Upgrade
Quick Ratio
-0.320.190.090.170.20
Upgrade
Current Ratio
-0.990.660.410.630.64
Upgrade
Return on Assets (ROA)
--3.43%-2.26%-3.50%1.72%-0.02%
Upgrade
Return on Capital (ROIC)
-4.10%-4.19%-2.92%-4.70%2.17%-0.02%
Upgrade
Return on Capital Employed (ROCE)
----4.90%-
Upgrade
Earnings Yield
-8.41%-10.93%-6.60%-15.29%-1.66%-56.71%
Upgrade
FCF Yield
-0.48%-9.32%13.35%0.94%1.18%
Upgrade
Buyback Yield / Dilution
-0.36%-0.26%---32.93%5.39%
Upgrade
Updated Jan 16, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.